PTEN and prostate cancer: The shift to aerobic glycolysis has recently has been linked to aggressive variant prostate cancer in prostate PDX models [60], and has also been shown to contribute to an immune suppressed tumor microenvironment in mouse models of PTEN deficient prostate cancer through modulation of tumor associated macrophage activity [61].